Analyst Scoreboard: 5 Ratings For Astrana Health
Portfolio Pulse from Benzinga Insights
Analysts have provided mixed ratings for Astrana Health (NASDAQ:ASTH) over the last quarter, with 4 bullish and 1 somewhat bullish ratings. The average 12-month price target has increased by 9.95% to $51.4. Key analysts have adjusted their ratings and price targets, reflecting their evolving views on the company's performance.
August 01, 2024 | 3:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Analysts have provided mixed ratings for Astrana Health (NASDAQ:ASTH) over the last quarter, with 4 bullish and 1 somewhat bullish ratings. The average 12-month price target has increased by 9.95% to $51.4. Key analysts have adjusted their ratings and price targets, reflecting their evolving views on the company's performance.
The increase in the average 12-month price target by 9.95% and the majority of bullish ratings suggest a positive short-term impact on Astrana Health's stock price. Analysts' adjustments to their ratings and price targets reflect their confidence in the company's performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100